[go: up one dir, main page]

NO320944B1 - Sammensetning, fremgangsmate og anvendelse av thymosinpolypeptider for behandling av infertilitet og forokning av fertiliseringskapasiteten til menn. - Google Patents

Sammensetning, fremgangsmate og anvendelse av thymosinpolypeptider for behandling av infertilitet og forokning av fertiliseringskapasiteten til menn. Download PDF

Info

Publication number
NO320944B1
NO320944B1 NO19951932A NO951932A NO320944B1 NO 320944 B1 NO320944 B1 NO 320944B1 NO 19951932 A NO19951932 A NO 19951932A NO 951932 A NO951932 A NO 951932A NO 320944 B1 NO320944 B1 NO 320944B1
Authority
NO
Norway
Prior art keywords
sperm
thymosin
penetration
promoting
antibody
Prior art date
Application number
NO19951932A
Other languages
English (en)
Norwegian (no)
Other versions
NO951932D0 (no
NO951932L (no
Inventor
Rajesh K Naz
Allan L Goldstein
Original Assignee
Einstein Coll Med
Washington University Medical
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Einstein Coll Med, Washington University Medical filed Critical Einstein Coll Med
Publication of NO951932D0 publication Critical patent/NO951932D0/no
Publication of NO951932L publication Critical patent/NO951932L/no
Publication of NO320944B1 publication Critical patent/NO320944B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/48—Reproductive organs
    • A61K35/52—Sperm; Prostate; Seminal fluid; Leydig cells of testes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/57581—Thymosin; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/04—Drugs for genital or sexual disorders; Contraceptives for inducing labour or abortion; Uterotonics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/26—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against hormones ; against hormone releasing or inhibiting factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Genetics & Genomics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • Biophysics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Pregnancy & Childbirth (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Toxicology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gynecology & Obstetrics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Cell Biology (AREA)
  • Epidemiology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Biotechnology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
NO19951932A 1992-11-17 1995-05-16 Sammensetning, fremgangsmate og anvendelse av thymosinpolypeptider for behandling av infertilitet og forokning av fertiliseringskapasiteten til menn. NO320944B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US97785192A 1992-11-17 1992-11-17
PCT/US1993/010620 WO1994012144A2 (en) 1992-11-17 1993-11-05 Treatment of infertility and enhancement of fertilization capacity in mammalian males

Publications (3)

Publication Number Publication Date
NO951932D0 NO951932D0 (no) 1995-05-16
NO951932L NO951932L (no) 1995-05-16
NO320944B1 true NO320944B1 (no) 2006-02-20

Family

ID=25525581

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19951932A NO320944B1 (no) 1992-11-17 1995-05-16 Sammensetning, fremgangsmate og anvendelse av thymosinpolypeptider for behandling av infertilitet og forokning av fertiliseringskapasiteten til menn.

Country Status (16)

Country Link
US (1) US5585234A (fi)
EP (1) EP0668876B1 (fi)
JP (1) JP3989531B2 (fi)
KR (1) KR100298858B1 (fi)
CN (1) CN1153589C (fi)
AU (1) AU679952B2 (fi)
CA (1) CA2148689C (fi)
DE (1) DE69330884T2 (fi)
DK (1) DK0668876T3 (fi)
ES (1) ES2164696T3 (fi)
FI (1) FI113007B (fi)
NO (1) NO320944B1 (fi)
PH (1) PH31119A (fi)
TW (1) TW234692B (fi)
WO (1) WO1994012144A2 (fi)
ZA (1) ZA938599B (fi)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE29811046U1 (de) * 1998-06-23 1998-09-10 Chang, Kwei-Tang, Panchiao, Taipeh Topfdeckel des Doppelfunktionsfiltertyps
US20030135876A1 (en) * 2002-01-16 2003-07-17 Larry Mobraaten Maintenance of genetic lines using cryopreserved sperm
IT201900016319A1 (it) * 2019-09-13 2021-03-13 Luigina Romani Timosina alfa 1 per l’uso nel trattamento dell’infertilità maschile da esposizione a metalli pesanti.

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4612365A (en) * 1980-03-25 1986-09-16 Max-Planck-Gesellschaft Zur Foederung Der Wissenschaften Medicaments containing alpha 1-thymosin and having an immuno regulatory action and alpha 1-thymosin fragments
EP0056594B1 (de) * 1981-01-14 1984-09-12 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Thymosin-alpha-1-Fragmente enthaltende Arzneimittel mit immunregulierender Wirkung und Thymosin-alpha-1-Fragmente
US4444757A (en) * 1981-11-16 1984-04-24 Research Corporation Use of thymosin as an anti-diabetes and anti-hypertensive disease agent
US4950590A (en) * 1986-01-13 1990-08-21 Board Of Governors Of Wayne State University Method and kit for assay for measurement of serum thymosin alpha1

Also Published As

Publication number Publication date
ES2164696T3 (es) 2002-03-01
FI113007B (fi) 2004-02-27
CA2148689C (en) 1998-12-29
TW234692B (fi) 1994-11-21
WO1994012144A3 (en) 1994-07-21
FI952381L (fi) 1995-07-11
WO1994012144A2 (en) 1994-06-09
EP0668876B1 (en) 2001-10-04
KR950703984A (ko) 1995-11-17
CN1153589C (zh) 2004-06-16
DK0668876T3 (da) 2001-12-03
DE69330884T2 (de) 2002-06-06
CN1112444A (zh) 1995-11-29
CA2148689A1 (en) 1994-06-09
EP0668876A1 (en) 1995-08-30
NO951932D0 (no) 1995-05-16
JP3989531B2 (ja) 2007-10-10
PH31119A (en) 1998-02-23
JPH08503705A (ja) 1996-04-23
AU5592194A (en) 1994-06-22
US5585234A (en) 1996-12-17
KR100298858B1 (ko) 2001-11-14
NO951932L (no) 1995-05-16
ZA938599B (en) 1994-06-28
AU679952B2 (en) 1997-07-17
FI952381A0 (fi) 1995-05-16
DE69330884D1 (de) 2001-11-08

Similar Documents

Publication Publication Date Title
Prasad et al. Evaluating zona pellucida structure and function using antibodies to rabbit 55 kDa ZP protein expressed in baculovirus expression system
EA010371B1 (ru) Тканевые протективные цитокины для защиты, восстановления и стимуляции реактивных клеток, тканей и органов
Lerum et al. Immunological impairment of pregnancy in mice by lactate dehydrogenase-X
Uto et al. Zona‐induced acrosome reaction of hamster spermatozoa
Bedford The contraceptive potential of fertilization: a physiological perspective
Talwar Immunological approaches to contraception and promotion of fertility
Naz et al. Thymosin alpha-1 enhances the fertilizing capacity of human sperm cell: implication in diagnosis and treatment of male infertility
AU679952B2 (en) Treatment of infertility and enhancement of fertilization capacity in mammalian males
Kaul et al. Immunocontraceptive potential of recombinant bonnet monkey (Macaca radiata) zona pellucida glycoprotein-C expressed in Escherichia coli and its corresponding synthetic peptide
Lea et al. Analysis of recombinant mouse zona pellucida protein 2 (ZP2) constructs for immunocontraception
Bandivdekar et al. Antibodies to human seminal plasma inhibin cause sperm agglutination and impairment of cervical mucus penetration and sperm-egg attachment
Vanage et al. Effect of immunization with synthetic peptide corresponding to region 1-17 of human seminal plasma inhibin on fertility of male rats
Alexander Contraceptive Vaccine Development: Future Prospects
Jones 5 Contraceptive vaccines
Yitbarek et al. Reproductive immunization of domestic and wild animals
US12202875B2 (en) GBD-SSTad-SSTad recombinant protein and method for producing and using same
Tesařík Immunoinhibition of human fertilization in vitro by antibodies to the cumulus oophorus intercellular matrix
Ramanathan et al. Analysis of epididymal proteins during sexual maturation in male albino mice
JP2006518193A (ja) 精子特異的リゾチーム様タンパク質
Prasad Zona pellucida antigens and the regulation of fertility: an
WO1999054354A9 (en) Sp22, a fertility-associated protein from sperm and a method for evaluating and affecting male fertility using it
Saxty et al. Sperm surface antigens and the prospects for contraceptive vaccine development
EP1605962A1 (en) Non-mammalian gnrh analogs and uses thereof in regulation of fertility and pregnancy
Moussakova Regional variations in the composition of the perinuclear theca of the rat spermatozoa
WO2001090185A2 (en) Pt32 sperm protein, sperm c-yes, oocyte cytoplasmic c-yes, and uses thereof

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees